Table 3.
IgM-SNEG | IgM-SPOS | Total | |
---|---|---|---|
BNT162b2 -Pfizer/BionTech | 573 (36.2%) | 1011 (63.8%) | 1584 |
Vaxzevria-AstraZeneca | 31 (83.8%) | 6 (16.2%) | 37 |
Spikevax-Moderna | 13 (86.7%) | 2 (13.3%) | 15 |
IgM-SNEG | IgM-SPOS | Total | |
---|---|---|---|
BNT162b2 -Pfizer/BionTech | 573 (36.2%) | 1011 (63.8%) | 1584 |
Vaxzevria-AstraZeneca | 31 (83.8%) | 6 (16.2%) | 37 |
Spikevax-Moderna | 13 (86.7%) | 2 (13.3%) | 15 |